BLX vs LOB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The stock exhibits weak financial health with a Piotroski F-Score of just 2/9, signaling significant fundamental concerns. Despite this, BLX trades at a discount to both Graham Number ($76.75) and intrinsic value ($63.64), supported by a low P/E of 7.90 and strong profitability margins above 72%. Recent earnings growth is exceptionally strong (YoY EPS +88.9%), but inconsistent historical earnings surprises and poor technical trend (10/100) offset optimism. The 5.27% dividend yield and low payout ratio add appeal, though insider sentiment is weak and analyst coverage is sparse.
LOB presents a stark contradiction between valuation and fundamental health. While the stock is priced attractively near its Graham Number ($38.44) and shows explosive YoY earnings growth (185.7%), the Piotroski F-Score of 2/9 indicates severe weakness in financial health. This fundamental fragility is compounded by bearish insider activity, specifically significant sales by the CEO and CFO. Despite analyst 'buy' recommendations and a high growth-based intrinsic value, the poor health score and insider sentiment suggest significant underlying risk.
Compare Another Pair
Related Comparisons
BLX vs LOB: Head-to-Head Comparison
This page compares Banco Latinoamericano de Comercio Exterior, S. A. (BLX) and Live Oak Bancshares, Inc. (LOB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.